|What We Do
There are 4 key elements to the Oxford BioPharama process
whereby we provide invaluable help to early stage projects. These are;
Discover, Assimilate, Integrate and Protect
Oxford BioPharma works in collaboration with our clients on
early stage projects to identify key pieces of scientific data
available in the public domain that are directly relevant to the
success of these projects. In the initial phase this process is client
lead using agreed search terms and phrases to interrogate literature
sources and public databases. Oxford BioPharma collates data
identified in this discovery stage and subjects it to the next stage
in the process i.e., Assimilate.
Oxford BioPharma analyses data identified in the Discovery
stage to help understand its meaning and determine its relevance to
the client’s project. When data has been identified as being of
potential interest, Oxford BioPharma analyses it within context to
examine its scientific validity and understand its meaning. This helps
determine the relevance of the data to the client’s project. Relevant
data sets are now introduced to the third stage in the process i.e.,
Oxford BioPharma places data sets that have come through the
Discover and Assimilate stages within the context of the client’s
project and helps to make sense of the broader picture. This
integration stage is crucial as it has the potential to drive the
project forward and provide new insights and new avenues for drug
discovery or technical innovation.
At Oxford BioPharma we recognise the importance of protecting
our client’s intellectual property. Protect is the final and most
critical stage of the Oxford BioPharma process and is client driven.
At this stage we help our clients exploit the
‘discover-assimilate-integrate’ process and assist them in preparing
and filing for patent applications.
By this process we help clients to keep abreast of their competitors
and ensure that their best ideas realise their full potential.